Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference33 articles.
1. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J. Clin. Oncol.,2008
2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N. Engl. J. Med.,2002
3. KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumour proportion score (TPS) ≥50%;Brahmer;Ann. Oncol.,2020
4. KEYTRUDA (pembrolizumab) [package insert],2020
5. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019